Eterna Therapeutics
ERNA
#9858
Rank
NZ$24.12 M
Marketcap
$0.47
Share price
-6.02%
Change (1 day)
-79.03%
Change (1 year)

Revenue for Eterna Therapeutics (ERNA)

Revenue in 2024 (TTM): NZ$0.94 Million

According to Eterna Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$1.03 Million. In 2023 the company made a revenue of NZ$0.1 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eterna Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.94 M783.27%
2023 NZ$0.1 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$24.18 B 2,339,030.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.97 M 4,829.77%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$92.52 B 8,947,582.01%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$2.02 B 195,816.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.57 M 2,760.01%๐Ÿ‡ฆ๐Ÿ‡บ Australia
NZ$29.00 B 2,804,415.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel